Article Versions Notes

Lutz SZ, Hennenlotter J, Franko A, Dannecker C, Fritsche L, Kantartzis K, Wagner R, Peter A, Stefan N, Fritsche A, et al. Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer. Journal of Clinical Medicine. 2022; 11(22):6762. https://doi.org/10.3390/jcm11226762

Lutz, Stefan Zoltán, Jörg Hennenlotter, Andras Franko, Corinna Dannecker, Louise Fritsche, Konstantinos Kantartzis, Róbert Wagner, Andreas Peter, Norbert Stefan, Andreas Fritsche, and et al. 2022. "Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer" Journal of Clinical Medicine 11, no. 22: 6762. https://doi.org/10.3390/jcm11226762

Lutz, S. Z., Hennenlotter, J., Franko, A., Dannecker, C., Fritsche, L., Kantartzis, K., Wagner, R., Peter, A., Stefan, N., Fritsche, A., Todenhöfer, T., Stenzl, A., Häring, H.-U., & Heni, M. (2022). Diabetes and the Prostate: Elevated Fasting Glucose, Insulin Resistance and Higher Levels of Adrenal Steroids in Prostate Cancer. Journal of Clinical Medicine, 11(22), 6762. https://doi.org/10.3390/jcm11226762